Briobacept (BR 3FC), a selective human monoclonal antibody, targets BLyS (BAFF) to induce B-cell apoptosis and is a recombinant glycoprotein comprising two BLyS receptor (BR3) molecules fused to the Fc domain of human IgG1. It has applications in the study of rheumatoid arthritis (RA) [1] [2].
CAS Number:
[869881-54-9]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted
